PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 43.90
+0.10 (0.23%)
Aug 3, 2026, 5:14 PM CET
PolyPeptide Group AG Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 74.59 | 68.28 | 95.71 | 37.53 | 136.3 |
Cash & Short-Term Investments | 74.59 | 68.28 | 95.71 | 37.53 | 136.3 |
Cash Growth | 9.25% | -28.66% | 155.03% | -72.47% | 692.09% |
Accounts Receivable | 60.86 | 82.5 | 76.67 | 46.49 | 65.23 |
Other Receivables | 13.38 | 11.78 | 9.53 | 10.03 | 6.26 |
Total Trade Receivables | 74.24 | 94.28 | 86.2 | 56.52 | 71.49 |
Inventory | 154.25 | 146.35 | 128.51 | 145.07 | 113 |
Other Current Assets | 21.8 | 19.31 | 16.19 | 12.45 | 10.81 |
Total Current Assets | 324.88 | 328.22 | 326.6 | 251.57 | 331.61 |
Net Property, Plant & Equipment | 458.79 | 388.99 | 324.11 | 297.29 | 235.44 |
Other Intangible Assets | 13.91 | 15.02 | 16.45 | 15.87 | 14.27 |
Other Long-Term Assets | 28.38 | 24.35 | 21.93 | 11.05 | 13.72 |
Total Assets | 825.96 | 756.58 | 689.09 | 575.78 | 595.04 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 74.31 | 73.26 | 60.91 | 45.93 | 28.48 |
Current Portion of Long-Term Debt | 0.54 | 30.64 | 41.25 | - | - |
Current Portion of Leases | 5.01 | 5.07 | 4.45 | 3.57 | 3.06 |
Unearned Revenue | 74.17 | 60.48 | 42.97 | 27.54 | 46.07 |
Other Current Liabilities | 32.5 | 25.06 | 26.87 | 19.02 | 26.35 |
Total Current Liabilities | 186.53 | 194.5 | 176.45 | 96.05 | 103.96 |
Long-Term Debt | 109.03 | 39.42 | 49.09 | - | - |
Long-Term Leases | 15.98 | 18.98 | 18.87 | 17.65 | 14.95 |
Other Long-Term Liabilities | 173.82 | 146.43 | 63.46 | 40.4 | 54.96 |
Total Long-Term Liabilities | 298.83 | 204.83 | 131.41 | 58.05 | 69.9 |
Total Liabilities | 485.36 | 399.33 | 307.86 | 154.11 | 173.87 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
Treasury Stock | -6.47 | -8.4 | -10.39 | -13.61 | -1.19 |
Additional Paid-in Capital | 203.16 | 203.55 | 204.35 | 206.72 | 216.75 |
Accumulated Other Comprehensive Income | 20.98 | 21.31 | 21.83 | 14.12 | 9.29 |
Retained Earnings | 122.63 | 140.48 | 165.14 | 214.15 | 196.03 |
Shareholders' Equity | 340.6 | 357.24 | 381.23 | 421.68 | 421.17 |
Total Liabilities & Equity | 825.96 | 756.58 | 689.09 | 575.78 | 595.04 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 130.57 | 94.12 | 113.66 | 21.22 | 18.01 |
Net Cash (Debt) | -55.98 | -25.84 | -17.96 | 16.31 | 118.3 |
Net Cash Growth | - | - | - | -86.21% | - |
Net Cash Per Share | -1.70 | -0.78 | -0.55 | 0.49 | 3.68 |
Book Value | 340.6 | 357.24 | 381.23 | 421.68 | 421.17 |
Book Value Per Share | 10.31 | 10.83 | 11.56 | 12.78 | 13.11 |
Tangible Book Value | 326.69 | 342.23 | 364.77 | 405.81 | 406.91 |
Tangible Book Value Per Share | 9.89 | 10.37 | 11.06 | 12.30 | 12.67 |